About Dapagliflozin (Amorphous) API

Therapeutic Category

Anti-Diabetic

API Technology

Synthetic

Dose Form

Oral Solids

Status

Available

Available Regulatory Filing

USDMF

CAS No

461432-26-8

Pharmacopoeia

Mechanism of Action

Sodium-glucose cotransporter 2 (SGLT2), expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. Dapagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, dapagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion

Indication

FARXIGA is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Valence Labs Pvt Ltd Expertise

Headquartered in Hyderabad, India, Valence Labs Pvt Ltd is one of the leading Active Pharmaceutical Ingredients (API) manufacturers and suppliers globally for Dapagliflozin (Amorphous) API. Valence Labs Pvt Ltd API business is a preferred partner to pharma companies across the US, Europe, Brazil, Latin America, Japan, China, Korea, Middle East and other emerging markets.

Valence Labs Pvt Ltd API business thrives on the deep technical strengths established over the last 30+ years in the development and manufacture of complex APIs such as steroids, peptides, complex long chain molecules and highly potent APIs (HPAPIs / oncology drugs). This expertise is complemented by our prowess in intellectual property and regulatory affairs which helps us consistently meet and exceed regulatory standards. Valence Labs Pvt Ltd Dapagliflozin (Amorphous) API is the outcome of the extensive expertise in R&D, IP, and Regulatory.

A key component in helping our customers be first to market is a responsive supply chain. We achieve this by making sure that all our facilities are operating efficiently and to the latest standards of quality, safety, and productivity. A strong interconnect between business and factories allows for a quick reaction to dynamic market changes, so that we can avert shortages and meet sudden surges in demand.

Valence Labs Pvt Ltd is a leading Dapagliflozin manufacturer offering a reliable and cost-effective solution for your SGLT2 inhibitor medication needs. Our dapagliflozin API is manufactured to meet the highest quality standards Contact us today to request a quote for bulk dapagliflozin price and discuss your specific requirements.